Rumor of a 50 percent reduction is false." Nancy Altman, president of the advocacy group Social Security Works, said in a statement: "The Social Security Administration is already chronically ...

The North Chicago, Ill., biopharmaceutical company said the European Commission, which generally follows the CHMP's advice, is expected to make a final decision in the first half of the year.

The European Commission (EC) will now review the CHMP recommendation, and a decision on the label ... CEPI has supported the development of more than 50 vaccine candidates or platform technologies ...

The European Commission (EC) will now review the CHMP recommendation ... CEPI has supported the development of more than 50 vaccine candidates or platform technologies against multiple known ...

For a limited time beginning February 27th, Amazon Music Unlimited is offering a four-month subscription at 50% off. For $5.49 per month, new subscribers of Amazon Music Unlimited can enjoy unlimited ...

The commission last month asked the CHMP to consider whether the new information would require an update of the positive opinion, and to consider whether the wording of the risk minimization ...

The Indianapolis drugmaker said the European Commission, which generally follows the CHMP's advice, is expected to make a final decision in the next one to two months. Eli Lilly previously won ...

(RTTNews) - Regeneron Pharmaceuticals (REGN) announced the CHMP has adopted a positive opinion recommending conditional marketing authorization of linvoseltamab to treat adults with relapsed and ...

Therefore, this positive CHMP opinion marks a crucial milestone toward introducing a more robust preventative solution against chikungunya in the EU. Broader accessibility will help provide ...

The CHMP has specifically backed Leqembi to treat mild cognitive impairment or mild dementia from Alzheimer’s but only for patients carrying one or no copy of the ApoE4 gene.

STOCKHOLM, Feb. 28, 2025 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today announced today that the Committee for Medicinal Products for Human Use (CHMP ...